Lifelongα-tocopherol supplementation increases the median life span of C57BL/6 mice in the cold but has only minor effects on oxidative damage by Selman, C. et al.
  
 
 
 
 
 
Selman, C., McLaren, J.S., Mayer, C., Duncan, J.S., Collins, A.R., Duthie, 
G.G., Redman, P., and Speakman, J.R. (2008) Lifelongα-tocopherol 
supplementation increases the median life span of C57BL/6 mice in the 
cold but has only minor effects on oxidative damage. Rejuvenation 
Research, 11 (1). pp. 83-96. ISSN 1549-1684 
 
 
Copyright ©  2008 Mary Ann Liebert, Inc. 
 
 
A copy can be downloaded for personal non-commercial research or 
study, without prior permission or charge  
 
The content must not be changed in any way or reproduced in any format 
or medium without the formal permission of the copyright holder(s)  
 
When referring to this work, full bibliographic details must be given 
 
 
 
 
 
http://eprints.gla.ac.uk/77239/ 
 
 
 
 
 
 
Deposited on:  27 March 2013 
 
 
 
 
 
 
 
 
 
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk 
REJUVENATION RESEARCH
Volume 11, Number 1, 2008
© Mary Ann Liebert, Inc.
DOI: 10.1089/rej.2007.0586
Lifelong -Tocopherol Supplementation Increases 
the Median Life Span of C57BL/6 Mice in the Cold 
but Has Only Minor Effects on Oxidative Damage
Colin Selman,1* Jane S. McLaren,1* Claus Mayer,2 Jackie S. Duncan,3 Andrew R. Collins,4,5
Garry G. Duthie,4 Paula Redman,1 and John R. Speakman1,3
ABSTRACT
The effects of dietary antioxidant supplementation on oxidative stress and life span are con-
fused. We maintained C57BL/6 mice at 7  2°C and supplemented their diet with -tocopherol
from 4 months of age. Supplementation significantly increased (p  0.042) median life span
by 15% (785 days, n  44) relative to unsupplemented controls (682 days, n  43) and also in-
creased maximum life span (oldest 10%, p  0.028). No sex or sex by treatment interaction ef-
fects were observed on life span, with treatment having no effect on resting or daily meta-
bolic rate. Lymphocyte and hepatocyte oxidative DNA damage and hepatic lipid peroxidation
were unaffected by supplementation, but hepatic oxidative DNA damage increased with age.
Using a cDNA macroarray, genes associated with xenobiotic metabolism were significantly
upregulated in the livers of female mice at 6 months of age (2 months supplementation). At
22 months of age (18 months supplementation) this response had largely abated, but various
genes linked to the p21 signaling pathway were upregulated at this time. We suggest that -
tocopherol may initially be metabolized as a xenobiotic, potentially explaining why previous
studies observe a life span extension generally when lifelong supplementation is initiated
early in life. The absence of any significant effect on oxidative damage suggests that the life
span extension observed was not mediated via any antioxidant properties of -tocopherol. We
propose that the life span extension observed following -tocopherol supplementation may
be mediated via upregulation of cytochrome p450 genes after 2 months of supplementation
and/or upregulation of p21 signaling genes after 18 months of supplementation. However,
these signaling pathways now require further investigation to establish their exact role in life
span extension following -tocopherol supplementation.
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INTRODUCTION
IT HAS BEEN LONG SUGGESTED that reactive oxy-gen species (ROS)-induced damage to pro-
teins, lipids, and DNA is a major contributor to
the biochemical, physiological, and functional
declines associated with aging.1,2 Nevertheless,
the exact role oxidative stress plays in mam-
malian aging remains controversial, despite
comparative data suggesting extended life
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span is associated with reduced ROS produc-
tion and/or a greater resistance to oxidative
stress,3–6 (but also7). Organisms possess a suite
of endogenous antioxidants, including super-
oxide dismutase, catalase, glutathione, and glu-
tathione peroxidase, to protect against oxida-
tive-induced damage. Moreover, exogenous
antioxidants such as -tocopherol and ascorbic
acid may confer protection against ROS dam-
age.1 Theoretically, dietary supplementation
with exogenous antioxidants may help sup-
port the endogenous antioxidant defenses by
scavenging ROS, thereby reducing oxidative
damage. This has resulted in dietary supple-
mentation, with various antioxidants being ad-
vocated as a potential therapy to extend both
life span and health span.8,9
Vitamin E is a lipid-soluble antioxidant
consisting of at least eight tocopherol and to-
cotrienol isomers (including - and -toco-
pherol), which acts as a chain-breaking antiox-
idant and a peroxyl radical scavenger in vivo.10
Vitamin E’s effects are however not restricted
to its role as an antioxidant as, for example, it
is known to be a potent stimulator of xenobi-
otic metabolism both in vivo and in vitro.11,12
However, the long-term benefits of vitamin E
supplementation appear confused. Some stud-
ies suggest supplementation can ameliorate
various cardiovascular, neurological, and ox-
idative stress parameters in mammals,13–15 and
others report little or no effect.16 Indeed, di-
etary vitamin E deficiency is associated with
various pathologies, including diabetes, ather-
osclerosis, and various cancers.11 The effects on
life span following vitamin E supplementation
in animal models are similarly confused. Using
a comparative approach, Zou et al.17 reported
that -tocopherol, but not -tocopherol, ex-
tended life span in Caenorhabditis elegans, but
that neither isoform had any life span effect in
Drosophila melanogastor or Anastrepha ludens. An
increase in median/mean life span has been re-
ported in various strains of mice following vi-
tamin E supplementation18–21 or following sup-
plementation with a mixed antioxidant diet
containing vitamins E and C.22 However, other
studies report no effect on life span or on ox-
idative stress following vitamin E supplemen-
tation or when using a mixed antioxidant
diet.14,23,24
There are several potential reasons why di-
etary antioxidants, such as vitamin E, have not
become robust and repeatable pro-longevity
treatments. Firstly, vitamin E supplementation
may indeed quench ROS and reduce oxidative
stress, but this may have no or little impact on
aging and life span if the importance of these
processes has been overestimated in vivo.17 Sec-
ondly, Vitamin E may scavenge ROS, and ROS
may be important in the aging process, but this
effect might be offset by a parallel compensat-
ing impacts on the endogenous antioxidant
system, or indeed on any system involved in
redox status or oxidative damage, similar to
those reported following vitamin C supple-
mentation.25,26 Thirdly, because body mass and
energy metabolism affect both free-radical pro-
duction and life span,7,27,28 if vitamin E sup-
plementation influences one or both of these
factors, this could offset any potential benefits.
Finally, age of initiation of supplementation
may be important. A significant increase in
mean life span was only observed in mice sup-
plemented from 2 and 9 months, but not at 16
or 22 months of age.19
It is well established that cold exposure ele-
vates metabolic rate, upregulates various an-
tioxidants, and increases both ROS production
and oxidative stress.29–32 Therefore, to examine
whether lifelong -tocopherol supplementa-
tion (initiated at 4 months of age) had a bene-
ficial effect on oxidative stress and life span, we
maintained C57BL/6 mice at 7  2°C over their
lifetime to potentially increase metabolic rate,
ROS production, and oxidative damage. We
have previously hypothesized26 that under
conditions of cold exposure, we would be more
likely to detect an effect of antioxidant supple-
mentation on oxidative stress and life span if
such an effect existed. We measured life span,
energy balance (resting metabolic rate, daily
energy expenditure by doubly-labeled water33)
hepatic lipid peroxidation (thiobarbituric acid-
reactive substances [TBAR]) using an HPLC
method,26,34 and lymphocyte and hepatocyte
DNA oxidative damage (modified Comet as-
say) in male and female C57BL/6 mice main-
tained in the cold (7  2°C) with ad libitum ac-
cess to either a control or an -tocopherol (550
mg/kg) supplemented diet. In addition, Clon-
tech cDNA- macroarrays were used to exam-
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ine hepatic gene expression changes with age
and -tocopherol supplementation in female
mice.
MATERIALS AND METHODS
Experimental design and mouse husbandry
C57BL/6 mice were purchased at 8 weeks of
age from a commercial breeder (Harlan, Bices-
ter, United Kingdom), individually housed in
cages (48  15  13 cm) at 22  2°C and un-
der a 16L/8D light/dark cycle (lights on 0600).
From 12 weeks of age onward, and as previ-
ously described,26 mice were maintained at 7 
2°C within a controlled temperature room (At-
lantic Cooling Services, Scassow, UK), with ac-
cess to bedding material and water and ad li-
bitum access to standard mouse diet (Rat and
Mouse Maintenance (RMI), Special Diets Ser-
vices, BP Nutrition, Witham, UK). Over a 4
week period of acclimation to 7  2°C, bedding
material was gradually removed and then at 16
weeks of age the mice were randomly assigned
to a control RM1 diet group (22 mg/kg ad libi-
tum -tocopherol) or a -tocopherol supple-
mented group (RM1  550 mg/kg of -toco-
pherol) equivalent to 25  the control diet. All
experiments followed institutional guidelines
for laboratory animal care and welfare under
license from the UK Home Office.
Longevity analysis
A total of 40 female (19 -tocopherol sup-
plemented, 21 control) and 47 male (25 -toco-
pherol supplemented, 22 control) mice were
used in the life span analysis. All individuals
were monitored daily following the guidelines
described previously,26 with Kaplan-Meier sur-
vival curves constructed using birth (mice pur-
chased at 8 weeks of age, see above) and known
death dates of each individual. The oldest 10%
survival was determined as the age of death of
the oldest 10% of mice in each experimental co-
hort.
An additional group of male and female mice
that followed the same husbandry protocol de-
scribed above were used to examine the effects
of lifelong -tocopherol supplementation on
gene expression profiles (females only), me-
tabolism (males and females), and oxidative
stress (males and females).
Metabolic studies
Resting metabolic rate (RMR) was determined
at 6 and 22 months of age (2 and 18 months fol-
lowing initiation of -tocopherol supplementa-
tion), using open-flow respirometry.35 All indi-
viduals had ad libitum access to food and water
prior to, but not during, measurements. Mice
were weighed (0.01 g) and then placed in an air-
tight Plexiglas chamber within a temperature-
controlled incubator (INL-401N-010, Gallen-
kamp, Loughborough, UK) at 7  0.1°C. Silica
gel-dried air was pumped (Charles Austin
Leighton Buzzard, UK) at 600–800 mL min1
(DM3A, Alexander Wright Flow Meter, UK), re-
dried, and then a sub-sample (150 mL min1)
was passed through a paramagnetic oxygen and
an infrared carbon dioxide analyzer (Series 1400,
Servomex Group, Crowburgh, UK). Energy ex-
penditure, corrected for standard temperature
and pressure, was calculated36 using the lowest
10 consecutive readings in oxygen concentration
(equivalent to 5 min within the chamber) and
used to calculate resting metabolic rate (mL O2
min1).
Daily energy expenditure (DEE) was esti-
mated in the same mice as RMR using the dou-
bly labeled water technique, as previously de-
scribed.33,37,38 On day one, the animals were
weighed (0.1 g Sartorius balance) and 0.15
mL of DLW (30 APE 18O, 15 APE 2H) was ad-
ministered (IP). Syringes were weighed before
and after administration (0.0001 g, Sartorius
balance) to calculate the mass of DLW injected.
Initial blood samples were taken after 1 h of
isotope equilibration to estimate initial isotope
enrichments. Final blood samples (80 L) were
taken as close as feasible to either 24 or 48 h af-
ter the initial blood sample to estimate isotope
elimination rates. Background enrichments
were evaluated from blood samples taken from
unlabeled animals in the same protocols.39 The
isotope ratios 18O:16O and 2H:1H were analyzed
using gas source isotope ratio mass spectrom-
etry (Optima, Micromass IRMS and Isochrom
G, Manchester, UK). Three high enrichment
standards were run each day alongside the
samples, with all raw data corrected to these
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standards to minimize any problems of inlet
cross contamination. Isotope enrichments were
converted to values of daily energy expendi-
ture using a single pool model.33
Comet assay
A modified Comet assay was employed to
determine hepatic and lymphocyte DNA ox-
idative damage in mice at 6 and 22 months of
age, as previously described.26 We used site-
specific bacterial repair enzymes endonuclease
III (ENDO III) and formamidopyrimidine-
DNA glycosylase (FPG) to increase the sensi-
tivity and specificity of the Comet assay.40
Damage was scored visually, with 100 comets
on each slide assigned a score from 0 to 4, de-
pending on the fraction of DNA pulled out into
the tail. The overall score for each slide was
therefore between 0 (undamaged) and 400
(completely damaged).
Thiobarbituric acid–reactive substances
Hepatic lipid peroxidation was estimated by
measuring thiobarbituric acid reactive sub-
stances (TBAR) using HPLC in 6- and 22-
month-old -tocopherol supplemented and
control mice as previously described.41 In brief,
liver homogenates (0.1 mL) in 0.05 M potas-
sium phosphate (pH 7.4) were incubated at
37°C in 2.5 mL buffer (final volume) and ex-
pressed as (nmol malonaldehyde/mg protein.
Hepatic -tocopherol
The levels of -tocopherol were measured in
liver homogenates using reverse-phase HPLC
and a fluorescent and visible detection method
adapted from Hess et al.42
Macroarray analysis
A sample of female mice (n  6 in each case)
from the -tocopherol supplemented and con-
trol diet groups were used for the macroarray
analysis at 6 and 22 months of age (i.e., 2 and 18
months following start of -tocopherol supple-
mentation). Samples were collected at the same
time each day to avoid any circadian changes in
liver metabolism potentially confounding treat-
ment effects. Samples were dissected, immedi-
ately frozen in liquid N2, and stored at 80°C
until use, with no pathology being evident in
any animal at this time. Total RNA was ex-
tracted using standard protocols,43 suspended
in 300 L of ultra-pure water and frozen at
80°C. Each sample (250 L of total RNA) was
treated following the Clontech Atlas Pure Sys-
tem (Clontech Laboratories, Mountain View,
CA, http://www.clontech.com/clontech)
protocol, including digestion in 25 L of RNase-
free Dnase 1. Isolated RNA was re-suspended
in 30 L ultra-pure water, yield and purity de-
termined (Agilent Technologies, Wokingham,
UK), and stored at 80°C until use. Clontech At-
las mouse stress cDNA expression arrays (Cat
#7749-1) were used containing a grid of 140 cD-
NAs spotted in duplicate on a nylon membrane.
Probe preparation, hybridization, and analysis
are described elsewhere.26
For the macroarray analysis, spot intensities
were log-transformed with respect to the base
2, resulting in differences of 1, 2, and 3 on the
log scale corresponding to fold changes of 2, 4,
and 8 on the original scale.26 An analysis of cor-
relations between the 24 slides revealed that 1
array from the 6-month -tocopherol supple-
mented mice did not correlate well with the
other 23 arrays, therefore this slide was elimi-
nated from further analysis. Normalization em-
ployed a two-stage strategy. The first normal-
ization stage involved calculating the average
intensity across the six slides or, in the case of
the 6-month -tocopherol mice, across five
slides (see above). Although numerous genes
might change in their average intensity, we as-
sumed that the overall distribution across
genes should more or less stay the same. For
this reason the group average was standard-
ized such that they had the same median and
the same inter-quartile range (used as a robust
measurement of scale). In the second normal-
ization stage, within an experimental group,
there was no reason to assume that genes were
systematically differentially expressed be-
tween individual animals. For this reason, we
used the standardized group average (see first
stage) and examined the six scatter-plots of this
average against each of the individual arrays
and assumed the data to scatter around the 45°
line of this plot. A nonlinear robust regression
(loess regression/normalization) was em-
ployed to remove any systematic departure
SELMAN ET AL.86
from this expected behavior (see Yang et al.44
for comparison). The 23 values were analyzed
in two-way analysis of variance (ANOVA) with
age (6 months, 22 months) and treatment (con-
trol, -tocopherol supplemented) as factors,
also allowing for interaction between age*treat-
ment (see Kerr et al.45 for a discussion of
ANOVA methods in a gene expression con-
text), resulting in three p values per gene. A to-
tal of 54 genes were identified with significant
differences in expression (p  0.05). By chance
alone, we predicted that only seven genes
(140*5%) would be expected to be significant,
indicating that most of the genes identified are
likely to be true positives.
Northern analysis
Total RNA was extracted from the same liver
samples used for the macroarrays using a guani-
dium isothiocyanate/phenol method, fraction-
ated on a 1.4% denaturing agarose gel, and
transferred overnight to a positively charged ny-
lon membrane (Amersham Biosciences, Little
Chalfont, UK). Following cross-linking and
hybridization at 42°C, we probed sequentially
for Cu-Zn-superoxide dismutase (5	 CTG-
CACGCCGCCCGACACAACATTATTGAG-
GT), catalase (5	 GAGAATCCATCCAGCGTT-
GATTACAGGTGA), and glutathione peroxi-
dase (5	 AGACCAAATGATGTACTTGGGGT-
CGGTCAT) mRNA using 5	 digoxigenin end-
labeled oligonucleotides (Eurogentec, South-
hampton, UK). Membranes were subsequently
stripped and hybridized for 18S rRNA (5	
CGCCTGCTGCCTTCCTTGGATGTGGTAG-
CCG). Signals were detected by chemilumi-
nescence (Applied Biosystems, Framingham,
UK), and quantified using ImageJ (Microsoft
Java Image, Redmond, WA).
Western analysis
Liver samples were homogenized in lysis
buffer, subsequently resolved on 12% Tris
glycine gels (Invitrogen, Paisley, UK), and trans-
ferred to nitrocellulose. Blots were probed us-
ing the primary antibodies p53 (#2524, Cell
Signaling Technology, Danvers, MA), phospho-
p53 (serine 15, #9284, Cell Signaling Technol-
ogy), and -Actin (#8277, Abcam, Cambridge,
UK); and secondary antibodies anti-rabbit HRP
(#7074, Cell Signaling Technology) or anti-
mouse HRP (#7076, Cell Signaling Technology).
Enhanced chemoluminescence was performed
(Pierce Perbio, Cramlington, UK) and blots were
subsequently stripped (Pierce Perbio).
Statistical analysis
All values reported are mean  standard er-
ror of the mean (SEM), except where indicated.
All data were analyzed using Minitab statistical
software, version 13 (Minitab, State College,
PA). Significance is indicated by p values  0.05.
RESULTS
We observed no significant sex effect on life
span (p  0.488) and no sex by treatment in-
teraction (p  0.495), therefore life span data
for male and female mice were pooled. Kaplan-
Meier analysis of survival (44 -tocopherol
supplemented and 43 control mice) indicated
that -tocopherol supplemented mice lived sig-
nificantly longer (Fig. 1; X2  4.157; p  0.042)
than control mice. Median life span of -toco-
pherol supplemented mice (785 days, range
367–952 days) was 103 days (15%) greater than
control mice (682 days, range 373–917 days).
The oldest 10% survival (mean  SEM) was
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FIG. 1. Life span of life-long -tocopherol supple-
mented (19 female and 25 male) and control mice (21 fe-
male and 22 male) maintained at 7  2°C. -tocopherol
supplemented mice lived significantly longer (log rank
test, X2  4.157; p  0.05) than control mice when main-
tained in the cold (7  2°C). Median life span of -toco-
pherol supplemented mice was 785 days (range 367–952
days) and control mice was 682 days (range 373–917
days). There was no significant sex or sex by treatment
interaction effects on life span (p  0.05). -tocopherol
supplemented mice indicated by solid line and control
mice by dotted line.
significantly greater (p  0.028) at 945  5 days
in -tocopherol supplemented mice compared
to control mice (894  9 days).
To determine the effects of -tocopherol sup-
plementation on metabolism (RMR and DEE),
we employed a general linear model with age
and treatment as factors and body mass as a
covariate in mice at 6 or 22 months of age (2 or
18 months following supplementation). There
were no significant age or treatment effects on
RMR, and no treatment by age interaction (Fig.
2A; p  0.05 in all cases). There was a signifi-
cant age-associated increase in DEE (Fig. 2B;
F  4.89, p  0.05) but no significant treatment
or age by treatment interaction effect.
Hepatocyte oxidative DNA damage in-
creased significantly with age (6 to 22 months
of age) when using the site-specific enzymes
endonuclease III (ENDO III, Fig. 3A; F  8.45,
p  0.008) and formamidopyrimidine-DNA
glycosylase (FPG; Fig. 3B; F  8.99, p  0.007),
but no treatment effect was observed (p 
0.05). In lymphocytes, -tocopherol did not al-
ter oxidative DNA damage compared to con-
trol mice, either when using the site-specific en-
zyme ENDO III (Fig. 3C; F  4.20, p  0.054) or
FPG (Fig. 3D; p  0.05). A significant age-re-
lated decrease in lipid peroxidation was seen
(Fig. 3E; F  22.14, p  0.001), but again no
treatment effect was observed. Hepatic -toco-
pherol was significantly elevated in the sup-
plemented mice (Fig. 3F; F  8.37, p  0.007)
relative to controls, with both a significant age
(F  7.03, p  0.013) and an age by treatment
interaction effect (F  5.95, p  0.021).
Table 1 summarizes those genes, their p val-
ues, and fold changes altered significantly in ex-
pression by age, but not treatment (-tocopherol
supplementation) or by an age by treatment in-
teraction. Table 2 shows the p values and fold
changes of genes where there was a significant
treatment effect in combination with an age ef-
fect, an age-by-treatment interaction, or a direct
treatment effect in the absence of any age-related
effect. We present the fold changes for the four-
way comparisons of 2 months against 18 months
following initiation of experiment (equivalent to
6 and 22 months of age) for both control and -
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FIG. 2. (A) There were no significant age or treatment effects on resting metabolic rate and no age by treatment (p 
0.05). (B) Daily energy expenditure significantly increased with age (F  4.89, p  0.05) but no significant treatment
or age-by-treatment interaction effect on DEE was observed (n  6–13).
A B
FIG. 3. Employing a general linear model with age and treatment as factors and body mass as a covariate indicated
that hepatic oxidative DNA damage increased significantly with age when using the site-specific enzymes endonu-
clease III (Endo III, 8.45, p  0.01) (A) and formamidopyrimidine-DNA glycosylase (FPG, F  8.99, p  0.01) (B), but
treatment had no effect. Lymphocyte oxidative DNA damage was unaffected by treatment and by age when using
ENDO III (p  0.05) (C) and FPG (p  0.05) (D). Mice supplemented with -tocopherol did not have significantly dif-
ferent levels of hepatic lipid peroxidation (thiobarbituric acid(reactive substances) compared to control mice (p  0.05),
although there was a significant age effect (F  22.14, p  0.001) (E). Hepatic -tocopherol was significantly elevated
in supplemented mice (F  8.37, p  0.007) (F), with a significant age (F  7.03, p  0.013) and age-by-treatment in-
teraction (F  5.95, p  0.021) observed. All mice are denoted by age, that is, 6 or 22 months of age, corresponding to
2 or 18 months of -tocopherol supplementation. Mean  SEM; n  5–12 in all cases.
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tocopherol supplemented mice and the treat-
ment against control comparisons at 2 and 18
months. Of the 23 genes that significantly
changed expression with age (Table 1) indepen-
dent of a treatment effect, only four genes, Gtbp,
Udpgt, Ung1, and Rad54, significantly increased
in expression. The remaining 19 genes all
showed a significant decrease in expression with
age (Table 2), several of which were involved in
cellular/oxidative stress and DNA repair, in-
cluding Cu-Zn SOD, Cat, Osp94, Mtj1, Xrcc1, 8-
oxo-dGTPase, and Msh2. Northern analysis
showed good agreement with our microarray
gene expression data (Supplemental Fig. 1), with
Cu-Zn SOD, Cat, and indeed glutathione per-
oxidase (Gpx was not present on the macroar-
ray), all elevated in the livers of 6-month-old
mice relative to 22-month-old mice. 
A total of 29 genes were significantly altered
in expression following -tocopherol supple-
mentation (Table 2), either as a direct treatment
effect (26 genes) or as a treatment-by-age inter-
action (14 genes). In agreement with Table 1, the
majority of the treatment-by-age effects on gene
expression were decreased (Table 2). We
grouped the 29 differentially regulated genes
into five broad functional sub-groups—cy-
tochrome p450s, detoxification, p21 signaling
cascade, repair/protection, and those genes un-
related to the above four functions. The cy-
tochrome p450 group included several associ-
ated with the p450 II subgroup, and along with
the genes in the phase 2 detoxification group,
the majority were significantly upregulated in
the -tocopherol treated group by around 2- to
3-fold after 2 months of supplementation (6
months of age). Only one cytochrome p450
(VIIb1) was downregulated following 2 months
of -tocopherol supplementation (Table 2), but
even including this down-regulated gene the av-
erage expression difference of these P450 and
detoxification genes between -tocopherol and
control mice following 2 months of treatment
was 235% (2.35 fold). However, by 18 months of
treatment (22 months of age), the transcriptional
changes between treatment and control groups
for these P450 and detoxification genes were
much reduced (Table 2).
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TABLE 1. SIGNIFICANT HEPATIC GENE EXPRESSION CHANGES WITH AGE
Age Age
fold-change fold-change
Gene Gene symbol p control -tocopherol
(A) Up-regulated
G/T-mismatch binding protein Gtbp 0.0011 1.93 1.88
Microsomal UDP-glucuronosyltransferase 1-7 Udpgt 0.0077 1.60 1.58
precursor
Uracil-DNA glycosylase Ung1 0.0376 1.33 1.11
Yeast DNA repair protein Rad52 homolog MmRad52 0.0356 1.45 1.30
(B) Down-regulated
Islet of langerhans regenerating protein 3 beta Reg III-beta 0.0013 2.42 1.47
DNA-repair protein Xrcc1 0.0019 1.68 1.43
T-complex protein 1 zeta subunit 2 Tcp1-zeta-2 0.0076 1.38 1.38
Islet of langerhans regenerating protein 3 alpha Reg 111-alpha 0.0081 1.89 1.54
Beta crystallin B2 Crybb2 0.0093 2.03 1.23
Gamma crystallin A-F Cryga-f 0.0104 1.50 1.84
7,8-dihydro-8-oxoguanine triphosphatase homolog 8-oxo-dGTPase 0.0126 1.37 1.32
Stress-activated c-jun N-terminal kinase 3 p49 0.0138 1.73 1.37
Extracellular superoxide dismutase precursor (Cu-Zn) Cu-Zn SOD 0.0144 1.52 2.09
Probable protein disulfide isomerase Erp60/Calr 0.0153 1.17 1.57
Extracellular signal-regulated kinase 6 p38 gamma 0.0175 1.42 1.36
Cytochrome P450 IA2 Cyp1a2 0.0211 1.52 1.53
5,6-dihydroxyindole-2-carboxylic acid oxidase precursor Tyrp1/Cat B 0.0215 1.37 1.43
DNAJ-like heat-shock protein from mouse tumor Mtj1 0.0236 1.11 1.66
DNA mismatch repair protein Msh2 0.0257 1.14 1.26
T-complex protein 1 eta subunit Tcp1-eta 0.0281 1.22 1.80
Catalase 1 Cat 0.0363 1.25 1.70
Osmotic stress protein; Osp94 0.0418 1.31 1.27
General transcription factor IIH polypeptide 1 Tfllh 0.0452 1.10 1.43
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In contrast, supplementation on genes asso-
ciated with the p21 signaling pathway were
only slightly upregulated by -tocopherol sup-
plementation at 6 months of age (20–76% above
control), with Mdm2 downregulated relative to
control levels (Table 2). However, by 18 months
of supplementation (22 months of age) the four
genes associated with this pathway were all
upregulated by on average 268% (2.68 fold),
with p21 upregulated 5.5 fold (554%), although
p53 transcript levels were not altered by treat-
ment. Using Western analysis, we show there
were no significant age, treatment, or age-by-
treatment interaction effects (Fig. 4; p  0.05 in
all cases) on either p53 or p53-serine protein
levels in the liver relative to control mice. The
effects of -tocopherol supplementation on
DNA repair and cellular protection against ox-
idative stress were less clear. After two months
of supplementation, several chaperones and
heat shock protein increased significantly in ex-
pression, but following 18 months of treatment
the fold-change of all these chaperones were re-
duced relative to the control group (Table 2).
DISCUSSION
The consumption of diets rich in antioxidants
have been advocated as a method to improve
and enhance health span and life span.9 Dietary
supplementation with -tocopherol increased
significantly the median and maximum (oldest
10%) life span of mice in this study housed at
7  2°C, in accord with previous studies that
maintained mice at more benign tempera-
tures.18,19,21,46 We initiated supplementation at
4 months of age, and the age of initiation and
duration of supplementation may be critical in
achieving positive life span effects,19 with stud-
ies observing a life span extension generally
starting vitamin E/-tocopherol supplementa-
tion earlier18,19,46 rather than later in life.14,24,47
The oxidative stress theory of aging suggests
that damage to proteins, lipids, and DNA are
a causal factor in the aging process.1 Increases
in lifetime metabolic rate are often assumed to
be positively associated with elevated ROS pro-
duction and hence oxidative stress, although
considerable debate exists on how metabolic
rate is related to both ROS production and to
life span.27,48–51 Whatever direction these ef-
fects take, we observed no consistent difference
in metabolic rate parameters following -toco-
pherol supplementation, suggesting the life
span effects were not mediated via this route.
Perhaps surprisingly, given the positive effect
on life span, there was no reduction in the ox-
idative stress parameters measured following
supplementation, with hepatic and lymphocyte
DNA oxidative damage and hepatic lipid per-
oxidation being unaffected relative to controls,
although hepatic DNA oxidative damage in-
creased with age. Our data confirms previous
studies showing variable effects of vitamin
E/-tocopherol supplementation on oxidative
stress.14,23,24,52,53
Consistent with the absence of a dramatic ef-
fect of -tocopherol supplementation on vari-
ous oxidative stress parameters, alterations in
expression of genes associated with protection
and repair against oxidative stress were simi-
larly small and inconsistent. Several genes
associated with protection against oxidative
stress and DNA damage, including Cu-Zn
SOD, catalase, 8-oxo-dGTPase, and Xrcc1 de-
creased with age but were not affected by treat-
ment. The age-associated declines in Cu-Zn
SOD and catalase expression were correlated
with Northern blot analysis of these same
genes in the same animals,26 with glutathione
peroxidase (Gpx was absent from the macroar-
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FIG. 4. Western blot scanning densitometry quantifica-
tion of the levels of total p53 and phosphorylated p53 at
serine15 in liver of -tocopherol supplemented mice at 6
months and 22 months of age relative to age-matched con-
trols. Protein levels were not significantly affected by age
or by treatment (p  0.05). Mean  SEM, with protein lev-
els expressed as a percentage of control values (100%);
n  5–6.
ray) also downregulated with age. The DNA
repair genes Rad51 and Ercc1 were downreg-
ulated by treatment, while several molecular
chaperones were upregulated by -tocopherol
supplementation. These changes were greatest
at 2 months of supplementation (6 months old),
but by 18 months the differences in expression
of most of these genes between supplemented
and control animals were reduced.
Our macroarray analysis indicated that eight
cytochrome P450 genes and five phase 2 detox-
ification genes were upregulated by 2- to 3-fold
after 2 months of supplementation. The initial
step of -tocopherol degradation is a w-hy-
droxylation of the side chain element by cy-
tochrome P450 hydroxylases.54,55 Supplemen-
tation with -tocopherol increases cytochrome
P450s levels in mice12,56 and activates the nu-
clear pregnane X receptor,57 which itself regu-
lates many genes linked to xenobiotic detoxifi-
cation, including several P450 enzymes.58 It is
feasible that -tocopherol is initially metabo-
lized as a xenobiotic, perhaps explaining why
previous studies generally only observe a life
span extension when supplementation is initi-
ated early in life. However, it has also been sug-
gested that induction of genes linked to xeno-
biotic metabolism plays a significant role in
longevity assurance in animals.59–61 Interest-
ingly, the induction of hepatic P450 genes after
18 months of supplementation was largely ab-
rogated, although as we examined only two
time-points, we do not know exactly when this
actually occurred. However, by 18 months of
supplementation, a significant upregulation of
several genes associated with the cyclin de-
pendent kinase inhibitor 1A (Cdki1a/p21) sig-
naling pathway was observed, with p38 Mapk
up 92%, Mdm2 up 89%, and p21 upregulated
554% (5.5-fold). The main regulator of p21 is
p53, with the antitumorigenic action of p53 me-
diated via p21. However, there was no evi-
dence that p53 protein levels (total and phos-
phorylated) were altered by -tocopherol
treatment. This suggests that -tocopherol may
modulate p21 expression independently of p53,
possibly via the promoter region of the p21
gene, which contains a C/EBPb response ele-
ment sensitive to -tocopherol.62
In summary, we demonstrate that lifelong
supplementation with -tocopherol (initiated
at 4 months of age) significantly extends me-
dian life span by 15% in cold exposed mice. No
treatment effects were observed on oxidative
stress or on oxidative stress-related gene ex-
pression. The induction of cytochrome P450
and detoxification genes early in the treatment
phase (after 2 months) suggests exogenous -
tocopherol may initially be identified as a xeno-
biotic and detoxified, and this upregulation
may be important in the life span extension ob-
served. By 18 months of supplementation (22
months of age) the expression of these genes
was almost normalized, at a time when the
treatment group showed upregulation of genes
involved in the p21 signaling pathway. Our ex-
perimental approach has therefore identified
two distinct signaling pathways, which are in-
duced in a temporal fashion, that may poten-
tially underlie the life span extension following
-tocopherol supplementation in cold-exposed
mice. These findings now require further in-
vestigation to establish their specific role in life
span extension following lifelong -tocopherol
supplementation in mice.
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Supplementary FIG. 1. Age-related gene expression as determined by Northern analysis. mRNA levels of Cu-Zn
superoxide dismutase, catalase, and glutathione peroxidase (not present on macroarray) at 6 months of age in con-
trol and -tocopherol supplemented mice relative to control or -tocopherol supplemented mice at 22 months of age.
Values expressed as percentage mean  SEM relative to expression levels at 22 months of age (100%, indicated by
line). All samples relative to 18S; n  5–6.
